FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34494911000001106: Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Jun 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104365601000001115 Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104591101000001110 Alkapamid XL 1.5mg tablets (HBS Healthcare Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) Is a Indapamide 1.5mg modified-release tablets true Inferred relationship Existential restriction modifier
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) Is a Indapamide 1.5mg m/r tablet false Inferred relationship Existential restriction modifier
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) Has active ingredient Indapamide true Inferred relationship Existential restriction modifier
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) Has specific active ingredient Indapamide true Inferred relationship Existential restriction modifier
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) Is a Alkapamid XL true Inferred relationship Existential restriction modifier
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) Is a Indapamide 1.5mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) 30 tablet 3 x 10 tablets Has AMP True Alkapamid XL1.5mg tablets (HBS Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start